Back to Browse Categories
Related journals you may be interested in:
Recent articles:
- 10 records -
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials
Imperial R, Mosalem O, Majeed U, Tran NH, Borad MJ, Babiker H
Clinical and Experimental Gastroenterology 2024, 17:121-134
Published Date: 18 April 2024
Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis
Yang SH, He YS, Zheng SQ, Zhang XJ, Dai H, Xue Y
Journal of Hepatocellular Carcinoma 2024, 11:737-746
Published Date: 18 April 2024
A Systematic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups
Sande Teige E, Sortvik U, Lied GA
Clinical and Experimental Gastroenterology 2024, 17:109-120
Published Date: 17 April 2024
Rectovaginal Fistulas Not Involving the Rectovaginal Septum Should Be Treated Like Anal Fistulas: A New Concept and Proposal for a Reclassification of Rectovaginal Fistulas
Garg P, Ladukar L, Yagnik VD, Bhattacharya K, Kaur G
Clinical and Experimental Gastroenterology 2024, 17:97-108
Published Date: 16 April 2024
An Overview of the Effects of Tenapanor on Visceral Hypersensitivity in the Treatment of Irritable Bowel Syndrome with Constipation
Singh P, Sayuk GS, Rosenbaum DP, Edelstein S, Kozuka K, Chang L
Clinical and Experimental Gastroenterology 2024, 17:87-96
Published Date: 10 April 2024
Adjuvant Transarterial Chemoembolization Plus Immunotherapy for Huge Hepatocellular Carcinoma: A Propensity Score Matching Cohort Study
Huang H, Liao W, Zhang K, Wang H, Cheng Q, Mei B
Journal of Hepatocellular Carcinoma 2024, 11:721-735
Published Date: 8 April 2024
Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors
Gonvers S, Martins-Filho SN, Hirayama A, Calderaro J, Phillips R, Uldry E, Demartines N, Melloul E, Park YN, Paradis V, Thung SN, Alves V, Sempoux C, Labgaa I
Journal of Hepatocellular Carcinoma 2024, 11:707-719
Published Date: 6 April 2024
Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy
Xie D, Li Z, Yuan J, Yin X, Chen R, Zhang L, Ren Z
Journal of Hepatocellular Carcinoma 2024, 11:693-705
Published Date: 4 April 2024
Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis
Wen Y, Lu L, Mei J, Ling Y, Guan R, Lin W, Wei W, Guo R
Journal of Hepatocellular Carcinoma 2024, 11:665-678
Published Date: 4 April 2024
Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery
Shao G, Ma Y, Qu C, Gao R, Zhu C, Qu L, Liu K, Li N, Sun P, Cao J
Journal of Hepatocellular Carcinoma 2024, 11:679-691
Published Date: 3 April 2024